ORA Sites

Search the OCGA site
OCGA staff contact info
Helpful links
Our address
Home


Note: You can also access these site areas via the menu above.

 Research Funding
 Proposal Preparation
 Forms and Templates
 Policies and Procedures
 Clinical Trials and Industry Research
 Research Policy & Compliance (including Conflicts of Interest in Research)
 Electronic Research Administration (Click here for Grants.gov Information. Last updated on 03/16/2007)
 Updated 1.31.2008  Subaward Initiation & Management
Research Policy Index -- An alphabetical listing of UCLA, UC, and Federal links to research policies, procedures, and information
Training Resources page (for access to the Glossary and Post-Award Administration Handbook)




 Office of Research Administration
 Office of Intellectual Property Administration (OIPA)
 Office of Extramural Fund Management (EFM)

 Office for the Protection of Research Subjects (OPRS)
 Office of Research Administration, Department of Medicine
 Research@UCLA
 Research | School of Medicine
 Strategic Research Initiatives North Campus

VICE CHANCELLOR’S MEMO ON DISCLOSING FINANCIAL INTERESTS RELEVANT TO FEDERALLY SPONSORED CONTRACTS AND GRANTS FOR RESEARCH
Posted on 07/18/2008
UCLA Procedure 925.3, “Disclosing Financial Interests Relevant to Federally Sponsored Contracts and Grants for Research” has been revised in response to suggestions made after a recent not-for-cause federal site visit

>> Click here to view the memo

Memo on Regental Policy on Research Funded by the Tobacco Industry
Posted on 07/18/2008
Vice Chancellor Peccei released a memo dated July 11, 2008 announcing the regental review and approval process for research funded by the tobacco industry.

>> Click here to view the memo

Memo on Change in On-line Non-PEAR Application
Posted on 07/11/2008
Vice Chancellor Peccei and Associate Vice Chancellor/Controller Abeles released a memo announcing a change in the On-Line Non-PEAR application in regards to Late Cost Transfers, effective July 14, 2008.

>> Click here to view the memo

Memo on Clinical Trial Subcontracts
Posted on 06/03/2008
Vice Chancellor Peccei has released a memo alerting the campus to the transition of responsibility from the Office of Contract and Grant Administration (OCGA) to the David Geffen School of Medicine Office of Clinical Trials (OCT) for the handling of incoming clinical trial subcontracts received from non-profit organizations in which the prime funding originates from a pharmaceutical company or similar industrial entity.

>> Click here to view the memo

VICE CHANCELLOR’S MEMO ON DISCLOSURE OF FINANCIAL INTERESTS IN NON-GOVERNMENTAL SPONSORS
Posted on 03/07/2008
UCLA Procedure 925.2, “Disclosing Financial Interests in Non-Governmental Sponsors of Contracts, Grants and Material Transfer Agreements for Research,” has been revised. It applies to all requests for research support submitted to for-profit and non-profit organizations.

>> Click here to view the document

Policy Updates: NIH Salary Cap
Posted on 02/15/2008
Excerpt: "Salaries paid under National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ) or Substance Abuse and Mental Health Administration (SAMHSA) grants, cooperative agreements, or contracts, are tied to..."

>> Click here to view the full document

OCGA Relocation
Posted on 09/12/2007
The Office of Contract & Grant Administration will be relocating on Friday September 14, 2007 to the Kinross building. The move will be completed on Monday September 17, 2007. The office WILL BE CLOSED on both days. Please note that our new address effective 09/08/2007 will be:

Office of Contract & Grant Administration
11000 Kinross Avenue, Suite 102
Box 951406
Los Angeles, CA 90095-1406

>> Click here to view VCR Peccei's memo

CALIFORNIA FORM 700-U NEW VALIDATION FEATURE
Posted on 05/11/2007
A validation feature has been added to the California Form 700-U, “Statement of Economic Interests for Principal Investigators.”  The validation version of the form will provide prompts to remind responders to complete each of the required fields. Upon completion, respondents will also receive a message if a supplemental form must also be completed.  The validation version of the Form 700-U can be completed on-line.  However, because of State requirements the form must still be printed and signed in ink prior to submission.  This validation version of Form 700-U is available on the Research Policy and Compliance Forms page.

>> Click here to view the Forms page

VICE CHANCELLORS' MEMO REGARDING BENEFIT RATE INCREASE
Posted on 03/14/2007
UCLA Vice Chancellors request 2% increase in benefit rate be used in proposal budgets to cover proposed increase in UCRP contribution for those payroll categories that pay into the UCRP - 5% merit and equity increase also to be budgeted

>> Click here to view the full memo

CHANGE IN STATE OF CALIFORNIA CONTRACTING POLICY
Posted on 02/02/2007
The State of California issued a policy change under which costs incurred prior to the full execution of State of California contracts and contract amendments will not be reimbursed by the State without a specific exception from the State Department of General Services.

>> Click here to view the document

MEMO FROM VCR ROBERTO PECCEI REGARDING  USE OF GRANTS.GOV FOR R01 APPLICATIONS
Posted on 01/19/2007
Excerpt: "Use of Grants.gov is required for submittal to NIH of all R01 applications submitted for the February 5, 2007 due date.  This is an update to my memo of a year ago regarding use of Grants.gov and a reminder that all applications must be received in final form at OCGA at least three working days prior to the due date, which for NIH R01s is January 31st...."

>> Click here to view the full memo
>> Further Grants.Gov Information

CHANGE IN SUBMISSION/RECEIPT DUE DATES FOR NIH, AHRQ AND NIOSH GRANT APPLICATIONS
Posted on 11/03/2006
The NIH has announced in Notice NOT-OD-07-001 that standard receipt dates for most NIH, AHRQ and NIOSH/CDC will change as of January 2007. The schedule of revised due dates applies to paper and electronic applications. Due dates for most grants will now be spread throughout the month.  Questions about submission of NIH, AQPH and NIOSH/DCD grants at UCLA should be directed to your OCGA Grant Analyst.  

>> Click here  for complete chart of due dates

GUIDANCE ON IMMIGRATION VISA APPLICATIONS, OUTSIDE LEGAL ASSISTANCE, AND INTERNAL PROCESSING RECHARGES
Posted on 10/27/2006
On October 24, 2006, VC Roberto Peccei issued a memo as guidance on the charging of immigration visa application fees, outside legal assistance fees, and visa processing recharges.  This memo supersedes a prior guidance document on this subject issued on October 30, 2003

>> Click here to view the memo

Responsibility for Handling Sponsored Research Related Agreements
Posted on 10/20/2006
Responsibility for handling different types of agreements for research or activities that are related to the conduct of research is distributed across several UCLA administrative offices. This matrix provides general guidance on evaluating an agreement and determining which administrative office(s) has responsibility for executing the agreement.

>> Click here to view the document

CLINICAL TRIALS DEFINITION
Posted on 09/08/2006
Starting in September of 2006 UCLA is adopting a new definition for clinical trials to determine whether projects qualify for the special 26% Total Direct Costs (TDC) indirect cost rate.  A memo has been issued with the updated definition.

>> Click here to view the memo

ORA-NEWS SERVICE CHANGES
Posted on 09/08/2006
Effective July 14 the ORA News Service (also known as RA-News is a self-managed listserv hosted on the campus listserv server (MailMan).  As of that date, all the ORA-NEWS mailing lists were combined into a single one.  

>> Click here for subscription/support

PI-INITIATED INDUSTRY FUNDED CLINICAL TRIALS INDIRECT COST RATE INCREASE, EFF. JULY 1, 2006
Posted on 07/12/2006
Last fall, Vice Chancellor for Research Roberto Peccei advised of an increase in the indirect cost rate for industry initiated and supported clinical trials to 26% (of total direct costs.)  Effective July 1, 2006, the same rate of 26% will be applied to Principal Investigator-initiated industry funded clinical trials.  Thus the indirect cost rate for all industry supported clinical trials will be 26% (applied to total direct costs.)

>> Click here to view the letter

JUNE 2006 MEMO FROM VC ROBERTO PECCEI REGARDING THE EFFORT REPORTING SYSTEM (ERS)
Posted on 06/16/2006
The Effort Reporting System (ERS) is a newly developed, fully automated system that will streamline the effort reporting process and address issues that exist within the current Personnel Activity Report (PAR) system.  It will refine and correct calculations, eliminate paper reporting, and provide mechanisms to adequately monitor effort reporting and ensure compliance with federal reporting requirements.  More information about ERS can be found at www.efm.ucla.edu/effortrpt.htm

>> Click here to view the memo

UCLA/RAND MOU AMENDMENT
Posted on 06/16/2006
An amendment to the UCLA/RAND MOU effective June 7, 2006 outlines the IRB review process for collaborative health services research involving human research subjects.  

>> Click here to view the document

CREATION OF UCLA EMBRYONIC STEM CELL RESEARCH OVERSIGHT COMMITTEE (ESCRO)
Posted on 05/03/2006
Vice Chancellor for Research Roberto Peccei recently released a memo announcing the creation of the human Embryonic Stem Cell Research Oversight (ESCRO) committee as an initial step to provide oversight of research involving human embryonic stem cells (hESC).  The establishment of the committee was first announced in VC Peccei’s memo on Preliminary Guidance on Conducting Human Embryonic Stem Cell Research at UCLA which was disseminated on August 2, 2005.   The ESCRO will help ensure that UCLA hESC research meets the highest scientific, ethical, and legal standards while facilitating the conduct of such research.  The policies, procedures, and forms for ESCRO review are at http://www.research.ucla.edu/researchpol/stemcelldocs.htm.

>> Click here to view the document

NON-COMPETITIVE FUNDING GUIDELINES
Posted on 01/27/2006
The University of California Guidelines on Non-Competitive Funding has recently been released.  These guidelines outline the circumstances that warrant requests to seek congressional-directed ("earmarked") research funding. Click here to read Executive Vice Chancellor and Provost Dan Neuman's memo, which provides UCLA's process for reviewing and evaluating earmark funding requests and includes relevant web links on the subject

>> Click here to view the document

MEMORANDUM REGARDING GRANTS.GOV
Posted on 01/26/2006
A memo regarding Grants.gov, a Federal electronic grant application system, was issued by VCR Roberto Peccei

>> Click here to view the memo

OCGA has established a new section with information, tips, and other resources dealing with Grants.gov under the Electronic Research Administration area of this site.  Click here to visit this new section

CHANGES TO OVERHEAD RATE FOR SPONSOR-INITIATED CLINICAL TRIALS
Posted on 10/07/2005
A memo regarding changes to the overhead rate for sponsor-initiated clinical trials has been issued by VCR Roberto Peccei.  The rate changes will be effective starting November 1, 2005

>> Click here to view the memo

CLINICAL TRIALS ANNOUNCEMENT
Posted on 10/07/2005
Effective immediately, Clinical Trials Industry Contracting for the Medical Sciences Campus is now being administered by the David Geffen School of Medicine

>> Click here to view full announcement

PRELIMINARY GUIDANCE ON CONDUCTING HUMAN EMBRYONIC STEM CELL RESEARCH UCLA
Posted on 08/05/2004
A memo regarding Preliminary Guidance on Conducting Human Embryonic Stem Cell Research (hESC) at UCLA was issued on August 2, 2005 by Roberto Peccei, Vice Chancellor for Research and Alan Robinson, Associate Vice Chancellor, Medical Sciences. It provides interim guidance to the campus research community until UCOP and other campuses develop consistent stem cell research policies compliant with state and federal regulations

>> Click here to see the memo

NIH PUBLIC ACCESS POLICY
Posted on 05/20/2005
Vice Chancellor Roberto Peccei and University Librarian Gary Strong recently distributed a campus memo announcing the NIH Public Access Policy, which is intended to enhance public access to NIH research. Although participation is voluntary, this policy strongly encourages NIH-funded investigators to deposit their peer-reviewed final manuscripts into the NIH National Library of Medicine's PubMed Central (PMC) for the purpose of providing a stable, permanent archive of peer-reviewed, NIH-funded research publications to other researchers and the public.

>> Click here to read the memo

ETHICAL CONDUCT OF ANIMAL AND HUMAN RESEARCH - A MESSAGE FROM VC ROBERTO PECCEI
On November 11, 2004 Vice Chancellor Roberto Peccei issued a message to the UCLA community regarding the collective responsibility of faculty, staff, and administration for the ethical conduct of animal and human research. The letter focuses on the responsibilities of the Institutional Official, the Institutional Review Boards (IRBs), Chancellor's Animal Research Committee (ARC), and the Office for Protection of Research Subjects (OPRS) for ensuring the protection of animal and human research subjects, facilitating the research mission of the University, and complying with Federal guidelines.

>> Click here to view the letter

NIH SALARY CAP Q&A UPDATE (01/14/2005)
The NIH Salary Cap Questions and Answers page has been updated. 

>> Click here to view the new version

UCLA's IMPLEMENTATION OF THE NIH TRAINING REQUIREMENTS FOR THE PROTECTION OF HUMAN SUBJECTS
On July 31, 2003, EVC Daniel Neuman released a memorandum updating the guidance provided by then-EVC Wyatt R. Hume on August 21, 2000. Please click the link below to dowload the memorandum in PDF format:

>> Click here to view the memo

MAY 2003 MEMORANDUM FROM VC ROBERTO PECCEI ON CONSISTENCY IN BUDGETING
On May 1, 2003, Roberto Peccei issued a memorandum to the campus on "Consistent Budgeting and Costing Guidance in Contract and Grant Proposals."

>> Click here to view the memo

NIH ERA COMMONS AVAILABLE
The NIH eRA Commons is now open to a select number of institutions, UCLA being one of them. Using the Commons, registered faculty can access proposal and award status, Notice of Grant Award documents, and summary sheets. Faculty also have the capability of submitting non-competing SNAP applications through the Commons.

To assist the campus with using the Commons, OCGA has developed an informational web page with user guides.

>> Click here for further information

08/06/2002 MEMO FROM THE OFFICE OF ENVIRONMENT, HEALTH AND SAFETY TO DEANS, DIRECTORS, CHAIRS, AND FACULTY
Mandatory Inventory of Select Agents and High Consequence Livestock Pathogens - September 1, 2003 - Deadline

>> Click here to read memo


Click here to view the archive



Last page update on 07/18/2008

Back to Top

Visit the home page

For questions/comments regarding this site's content, e-mail the OCGA Web Team
For technical questions/comments only, e-mail the Webmaster.
©2007-2008 The Regents of the University of California